Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for telangiectasia macularis eruptiva perstans.
4 publications have been identified in PubMed for telangiectasia macularis eruptiva perstans. Research spans Other (50%) and Case Report / Case Series (50%).
King A (2025). [PMID: 40491135](https://pubmed.ncbi.nlm.nih.gov/40491135/). *J Cutan Med Surg*. [Other]
Kikina S (2025). [PMID: 41246743](https://pubmed.ncbi.nlm.nih.gov/41246743/). *Cureus*. [Case Report / Case Series]
Urbina F (2025). [PMID: 40506942](https://pubmed.ncbi.nlm.nih.gov/40506942/). *Diagnostics (Basel)*. [Other]
Harb M (2025). [PMID: 40546465](https://pubmed.ncbi.nlm.nih.gov/40546465/). *Cureus*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:57 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
AI-curated news mentioning telangiectasia macularis eruptiva perstans
Updated Sep 4, 2026
A recent case report details the diagnosis of telangiectasia macularis eruptiva perstans using dermoscopy and reflectance confocal microscopy. This study highlights the potential of advanced imaging techniques in identifying this rare skin condition.